Jennifer R. Brown, MD, PhD

President of the Society of Hematologic Oncology

Articles by Jennifer R. Brown, MD, PhD

Jennifer R. Brown, MD, PhDChronic Lymphocytic Leukemia | October 9, 2024
The past year in CLL care has seen promising new study findings on BTK inhibition and regulatory approvals.
Jennifer R. Brown, MD, PhDChronic Lymphocytic Leukemia | December 16, 2023
Dr. Brown presented updated results from the ALPINE study at ASH 2023.
Cecilia BrownChronic Lymphocytic Leukemia | February 8, 2024
Dr. Brown shares what CLL news and session she's watching at the Eleventh Annual Meeting of SOHO.
Jennifer R. Brown, MD, PhDMeeting News | September 7, 2023
SOHO President Jennifer Brown, MD, PhD, talks about why she chose personalized medicine as this year's theme.
Jennifer R. Brown, MD, PhDViewpoints | February 8, 2024
SOHO President Jennifer Brown, MD, PhD, reflects on the upcoming 11th SOHO Annual Meeting.
Leah SherwoodChronic Lymphocytic Leukemia | February 8, 2024
In this short from the 2023 EHA Congress, Dr. Brown talks about the genomic evolution of pirtobrutinib resistance.
Jennifer R. Brown, MD, PhDPrint | January 13, 2023
Jennifer R. Brown, MD, PhD, and Anthony Mato, MD, MSCE, debate combinations versus sequencing approaches in CLL.
Jennifer R. Brown, MD, PhDChronic Lymphocytic Leukemia | February 8, 2024
SOHO President Jennifer R. Brown, MD, PhD, speaks about the phase III ALPINE study, which compared BTK inhibitors in CLL/SLL.
Chadi Nabhan, MD, MBA, FACPChronic Lymphocytic Leukemia | January 10, 2023
Jennifer R. Brown, MD, PhD; President of SOHO chats with Chadi Nabhan, MD, on the ALPINE study.